Thrombosis in myeloproliferative neoplasms: Treatment outcomes of direct oral anticoagulants and vitamin K antagonists

CONCLUSION: Our data did not demonstrate a significant difference in recurrent TEs or bleeding events in patients with MPN-associated thrombosis anticoagulated with either DOACs or VKAs.PMID:34532628 | PMC:PMC8440942 | DOI:10.1002/rth2.12574

Source: Thrombosis and Haemostasis - September 17, 2021 Category: Hematology Authors: Kateryna Fedorov Swati Goel Margarita Kushnir Henny H Billett Source Type: research